We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sorrento Therapeutics, Mount Sinai Partner on Triple COVID-19 Antibody Treatment
Sorrento Therapeutics, Mount Sinai Partner on Triple COVID-19 Antibody Treatment
California biotech firm Sorrento Therapeutics and New York City’s Mount Sinai Health System are teaming up to test and develop a triple antibody cocktail that could potentially treat or help prevent COVID-19.